Per a court order, HHS is required to restore this website to its version as of 12:00 AM on January 29, 2025. Information on this page may be modified and/or removed in the future subject to the terms of the court’s order and implemented consistent with applicable law. Any information on this page promoting gender ideology is extremely inaccurate and disconnected from truth. The Trump Administration rejects gender ideology due to the harms and divisiveness it causes. This page does not reflect reality and therefore the Administration and this Department reject it.

Management of Multidrug-Resistant Organisms Guidelines

About this resource:

HHS Non-systematic Review

Source: Centers for Disease Control and Prevention

Last Reviewed: February 2017

This set of guidelines offers recommendations
to help all health care providers prevent infections due to multidrug-resistant organisms (MDROs). It categorizes the recommendations by type, including:

  • Administrative measures
  • Education and training of health care personnel
  • Systems for effective treatment of infections and correct use of antibiotics 
  • Surveillance
  • Infection control precautions
  • Environmental measures

Prevention and control of MDROs requires both the leadership of administrators and scientific leaders and a commitment of financial and human resources.

Read more about this resource

Objectives related to this resource (2)

Suggested Citation

1.

Siegel, J., Rhinehart, E., Jackson, M., Chiarello, L., and the Healthcare Infection Control Practices Advisory Committee. (2006). Management of Multidrug-Resistant Organisms in Healthcare Settings, 2006. Retrieved from https://www.cdc.gov/infection-control/hcp/mdro-management